tiprankstipranks
Trending News
More News >
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (HK:8189)
:8189
Hong Kong Market
Advertisement

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (8189) Financial Statements

Compare
2 Followers

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Financial Overview

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H's market cap is currently HK$971.15M. The company's EPS TTM is HK$-0.015; its P/E ratio is ―; Tianjin TEDA Biomedical Engineering Co. Ltd. Class H is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 385.48M¥ 398.00M¥ 449.68M¥ 476.38M¥ 369.36M
Gross Profit¥ 16.97M¥ 21.37M¥ 16.40M¥ 45.60M¥ 40.39M
Operating Income¥ -28.38M¥ -9.83M¥ -20.80M¥ -4.44M¥ -21.75M
EBITDA¥ -20.19M¥ 4.79M¥ -2.26M¥ -29.86M¥ -14.65M
Net Income¥ -27.80M¥ -20.16M¥ -26.65M¥ -44.78M¥ -50.36M
Balance Sheet
Cash & Short-Term Investments¥ 25.40M¥ 5.93M¥ 9.55M¥ 29.78M¥ 35.53M
Total Assets¥ 332.53M¥ 303.28M¥ 337.20M¥ 347.60M¥ 392.92M
Total Debt¥ 159.92M¥ 83.56M¥ 96.01M¥ 90.34M¥ 54.65M
Net Debt¥ 134.52M¥ 77.62M¥ 89.16M¥ 63.90M¥ 41.12M
Total Liabilities¥ 304.09M¥ 238.70M¥ 253.48M¥ 237.24M¥ 237.77M
Stockholders' Equity¥ 22.15M¥ 49.95M¥ 72.67M¥ 100.78M¥ 143.04M
Cash Flow
Free Cash Flow¥ -28.83M¥ -15.62M¥ -21.62M¥ -40.38M¥ 21.96M
Operating Cash Flow¥ -26.27M¥ -13.15M¥ -12.82M¥ -6.68M¥ 35.99M
Investing Cash Flow¥ -37.24M¥ -467.44K¥ -12.93M¥ -8.51M¥ -26.51M
Financing Cash Flow¥ 82.95M¥ 12.73M¥ 6.17M¥ 28.10M¥ -20.19M
Currency in CNY

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Earnings and Revenue History

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Debt to Assets

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Cash Flow

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis